Promotion of Remyelination by Immunoglobulins: Implications for the Treatment of Multiple Sclerosis

E-ISSN： 1873-4286|12|2|241-249

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.2, 2006-01, pp. : 241-249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal Antibodies and Recombinant Immunoglobulins for the Treatment of Multiple Sclerosis

By Gensicke Henrik Leppert David Yaldizli Özgür Lindberg Raija L.P. Mehling Matthias Kappos Ludwig Kuhle Jens

CNS Drugs, Vol. 26, Iss. 1, 2012-01 ,pp. : 11-37

Adis International

Access to resources Recommend Favorite

Regulation of Self-Reactive T Cells by Human Immunoglobulins- Implications for Multiple Sclerosis Therapy

Current Pharmaceutical Design, Vol. 9, Iss. 3, 2003-01 ,pp. : 245-256

Bentham Science Publishers

Access to resources Recommend Favorite

Differentiation of Multiple Sclerosis Subtypes: Implications for Treatment

By Bitsch A.

CNS Drugs, Vol. 16, Iss. 6, 2002-01 ,pp. : 405-418

Adis International

Access to resources Recommend Favorite

Immune System Induction of Nerve Growth Factor in an Animal Model of Multiple Sclerosis: Implications in Re-Myelination and Myelin RepairATION AND MYELIN REPAIR

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 8, 2015-10 ,pp. : 1069-1078

Bentham Science Publishers

Access to resources Recommend Favorite

Multiple sclerosis and its treatment

By Giovannoni Gavin Miller David H

Clinical Medicine, Vol. 33, Iss. 4, 1999-07 ,pp. : 315-322

Royal College Of Physicians

Access to resources Recommend Favorite